経カテーテル僧帽弁修復・置換の世界市場 - 機会分析・産業予測：製品別、適応症別（2020年～2030年）

世界の経カテーテル僧帽弁修復・置換市場の成長を促進する主な要因は、高齢者層における心臓疾患の発生率の増加、技術の進歩、新規僧帽弁の導入などです。

しかし、管理機関による新規僧帽弁ステント承認のための厳しい規制、僧帽弁手術の高コストやこの手術に伴うリスクが、市場の成長を抑制しています。一方、未開拓の経済地域における継続的な製品革新と新規僧帽弁の導入は、主要企業に有利な機会を創出すると予想されます。

当レポートでは、世界の経カテーテル僧帽弁修復・置換市場を調査分析し、市場概要、セグメント別・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

• 市場の定義と範囲
• 主な調査結果
  • 主な投資ポケット
• ポーターのファイブフォース分析
• 主要企業のポジショニング
• 市場力学
  • 促進要因
  • 抑制要因
  • 市場機会
• 市場におけるCOVID-19の影響分析

第4章 経カテーテル僧帽弁修復・置換市場：製品別

• 概要
  • 市場規模と予測
• メカニカルバルブ
  • 主要な市場動向、成長要因および機会
  • 市場規模と予測：地域別
  • 市場分析：国別
• 生体補綴組織（生物学的）バルブ
  • 主要な市場動向、成長要因および機会
  • 市場規模と予測：地域別
  • 市場分析：国別

第5章 経カテーテル僧帽弁修復・置換市場：適応症別

• 概要
  • 市場規模と予測
• 僧帽弁狭窄症
  • 主要な市場動向、成長要因および機会
  • 市場規模と予測：地域別
  • 市場分析：国別
• 僧帽弁逸脱
  • 主要な市場動向、成長要因および機会
  • 市場規模と予測：地域別
  • 市場分析：国別
• 僧帽弁逆流
  • 主要な市場動向、成長要因および機会
  • 市場規模と予測：地域別
  • 市場分析：国別

第6章 経カテーテル僧帽弁修復・置換市場：地域別

• 概要
  • 市場規模と予測
• 北米
  • 主な動向と機会
  • 北米市場の規模と予測：製品別
  • 北米市場の規模と予測：適応症別
  • 北米市場の規模と予測：国別
    • 米国
    • カナダ
    • メキシコ
• 欧州
  • 主な動向と機会
  • 欧州市場の規模と予測：製品別
  • 欧州市場の規模と予測：適応症別
  • 欧州市場の規模と予測：国別
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他欧州
• アジア太平洋
  • 主な動向と機会
  • アジア太平洋市場の規模と予測：製品別
  • アジア太平洋市場の規模と予測：適応症別
  • アジア太平洋市場の規模と予測：国別
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋
• ラテンアメリカ・中東・アフリカ
  • 主な動向と機会
  • ラテンアメリカ・中東・アフリカ市場の規模と予測：製品別
  • ラテンアメリカ・中東・アフリカ市場の規模と予測：適応症別
  • ラテンアメリカ・中東・アフリカ市場の規模と予測：国別
    • ブラジル
    • サウジアラビア
    • 南アフリカ
    • その他ラテンアメリカ・中東・アフリカ

第7章 企業情勢

• イントロダクション
• 主な成功戦略
• 主要10社の製品マッピング
• 競合ダッシュボード
• 競合ヒートマップ
• 主な発展

第8章 企業プロファイル

• ABBOTT LABORATORIES
• BIOTRONIK SE & CO. KG
• COLIBRI HEART VALVE, LLC.
• EDWARDS LIFE SCIENCE CORPORATION
• HLT, INC.
• LIVANOVA PLC
• MEDTRONIC PLC
• NEOVASC INC.
• NEOCHORD INC.
• CORAMAZE TECHNOLOGIES GMBH.

LIST OF TABLES

• TABLE 1. GLOBAL TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 2. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET SIZE, FOR MECHANICAL VALVES, BY REGION, 2020-2030 ($MILLION)
• TABLE 3. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET FOR MECHANICAL VALVES, BY COUNTRY, 2020-2030 ($MILLION)
• TABLE 4. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET SIZE, FOR BIOPROSTHETIC TISSUE (BIOLOGICAL) VALVES, BY REGION, 2020-2030 ($MILLION)
• TABLE 5. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET FOR BIOPROSTHETIC TISSUE (BIOLOGICAL) VALVES, BY COUNTRY, 2020-2030 ($MILLION)
• TABLE 6. GLOBAL TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 7. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET SIZE, FOR MITRAL VALVE STENOSIS, BY REGION, 2020-2030 ($MILLION)
• TABLE 8. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET FOR MITRAL VALVE STENOSIS, BY COUNTRY, 2020-2030 ($MILLION)
• TABLE 9. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET SIZE, FOR MITRAL VALVE PROLAPSE, BY REGION, 2020-2030 ($MILLION)
• TABLE 10. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET FOR MITRAL VALVE PROLAPSE, BY COUNTRY, 2020-2030 ($MILLION)
• TABLE 11. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET SIZE, FOR MITRAL VALVE REGURGITATION, BY REGION, 2020-2030 ($MILLION)
• TABLE 12. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET FOR MITRAL VALVE REGURGITATION, BY COUNTRY, 2020-2030 ($MILLION)
• TABLE 13. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY REGION, 2020-2030 ($MILLION)
• TABLE 14. NORTH AMERICA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 15. NORTH AMERICA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 16. NORTH AMERICA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY COUNTRY, 2020-2030 ($MILLION)
• TABLE 17. U.S. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 18. U.S. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 19. CANADA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 20. CANADA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 21. MEXICO TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 22. MEXICO TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 23. EUROPE TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 24. EUROPE TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 25. EUROPE TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY COUNTRY, 2020-2030 ($MILLION)
• TABLE 26. GERMANY TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 27. GERMANY TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 28. FRANCE TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 29. FRANCE TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 30. U.K. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 31. U.K. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 32. ITALY TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 33. ITALY TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 34. SPAIN TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 35. SPAIN TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 36. REST OF EUROPE TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 37. REST OF EUROPE TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 38. ASIA-PACIFIC TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 39. ASIA-PACIFIC TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 40. ASIA-PACIFIC TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY COUNTRY, 2020-2030 ($MILLION)
• TABLE 41. JAPAN TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 42. JAPAN TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 43. CHINA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 44. CHINA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 45. INDIA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 46. INDIA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 47. AUSTRALIA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 48. AUSTRALIA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 49. SOUTH KOREA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 50. SOUTH KOREA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 51. REST OF ASIA-PACIFIC TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 52. REST OF ASIA-PACIFIC TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 53. LAMEA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 54. LAMEA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 55. LAMEA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY COUNTRY, 2020-2030 ($MILLION)
• TABLE 56. BRAZIL TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 57. BRAZIL TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 58. SAUDI ARABIA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 59. SAUDI ARABIA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 60. SOUTH AFRICA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 61. SOUTH AFRICA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 62. REST OF LAMEA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT, 2020-2030 ($MILLION)
• TABLE 63. REST OF LAMEA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS, 2020-2030 ($MILLION)
• TABLE 64.ABBOTT LABORATORIES: COMPANY SNAPSHOT
• TABLE 65.ABBOTT LABORATORIES: OPERATING SEGMENTS
• TABLE 66.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
• TABLE 67.ABBOTT LABORATORIES: NET SALES,
• TABLE 68.ABBOTT LABORATORIES: KEY STRATERGIES
• TABLE 69.BIOTRONIK SE & CO. KG: COMPANY SNAPSHOT
• TABLE 70.BIOTRONIK SE & CO. KG: OPERATING SEGMENTS
• TABLE 71.BIOTRONIK SE & CO. KG: PRODUCT PORTFOLIO
• TABLE 72.BIOTRONIK SE & CO. KG: NET SALES,
• TABLE 73.BIOTRONIK SE & CO. KG: KEY STRATERGIES
• TABLE 74.COLIBRI HEART VALVE, LLC.: COMPANY SNAPSHOT
• TABLE 75.COLIBRI HEART VALVE, LLC.: OPERATING SEGMENTS
• TABLE 76.COLIBRI HEART VALVE, LLC.: PRODUCT PORTFOLIO
• TABLE 77.COLIBRI HEART VALVE, LLC.: NET SALES,
• TABLE 78.COLIBRI HEART VALVE, LLC.: KEY STRATERGIES
• TABLE 79.EDWARDS LIFE SCIENCE CORPORATION: COMPANY SNAPSHOT
• TABLE 80.EDWARDS LIFE SCIENCE CORPORATION: OPERATING SEGMENTS
• TABLE 81.EDWARDS LIFE SCIENCE CORPORATION: PRODUCT PORTFOLIO
• TABLE 82.EDWARDS LIFE SCIENCE CORPORATION: NET SALES,
• TABLE 83.EDWARDS LIFE SCIENCE CORPORATION: KEY STRATERGIES
• TABLE 84.HLT, INC.: COMPANY SNAPSHOT
• TABLE 85.HLT, INC.: OPERATING SEGMENTS
• TABLE 86.HLT, INC.: PRODUCT PORTFOLIO
• TABLE 87.HLT, INC.: NET SALES,
• TABLE 88.HLT, INC.: KEY STRATERGIES
• TABLE 89.LIVANOVA PLC: COMPANY SNAPSHOT
• TABLE 90.LIVANOVA PLC: OPERATING SEGMENTS
• TABLE 91.LIVANOVA PLC: PRODUCT PORTFOLIO
• TABLE 92.LIVANOVA PLC: NET SALES,
• TABLE 93.LIVANOVA PLC: KEY STRATERGIES
• TABLE 94.MEDTRONIC PLC: COMPANY SNAPSHOT
• TABLE 95.MEDTRONIC PLC: OPERATING SEGMENTS
• TABLE 96.MEDTRONIC PLC: PRODUCT PORTFOLIO
• TABLE 97.MEDTRONIC PLC: NET SALES,
• TABLE 98.MEDTRONIC PLC: KEY STRATERGIES
• TABLE 99.NEOVASC INC.: COMPANY SNAPSHOT
• TABLE 100.NEOVASC INC.: OPERATING SEGMENTS
• TABLE 101.NEOVASC INC.: PRODUCT PORTFOLIO
• TABLE 102.NEOVASC INC.: NET SALES,
• TABLE 103.NEOVASC INC.: KEY STRATERGIES
• TABLE 104.NEOCHORD INC.: COMPANY SNAPSHOT
• TABLE 105.NEOCHORD INC.: OPERATING SEGMENTS
• TABLE 106.NEOCHORD INC.: PRODUCT PORTFOLIO
• TABLE 107.NEOCHORD INC.: NET SALES,
• TABLE 108.NEOCHORD INC.: KEY STRATERGIES
• TABLE 109.CORAMAZE TECHNOLOGIES GMBH.: COMPANY SNAPSHOT
• TABLE 110.CORAMAZE TECHNOLOGIES GMBH.: OPERATING SEGMENTS
• TABLE 111.CORAMAZE TECHNOLOGIES GMBH.: PRODUCT PORTFOLIO
• TABLE 112.CORAMAZE TECHNOLOGIES GMBH.: NET SALES,
• TABLE 113.CORAMAZE TECHNOLOGIES GMBH.: KEY STRATERGIES

LIST OF FIGURES

• FIGURE 1.TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET SEGMENTATION
• FIGURE 2.TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030
• FIGURE 3.TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030
• FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
• FIGURE 5.PORTER FIVE-1
• FIGURE 6.PORTER FIVE-2
• FIGURE 7.PORTER FIVE-3
• FIGURE 8.PORTER FIVE-4
• FIGURE 9.PORTER FIVE-5
• FIGURE 10.TOP PLAYER POSITIONING
• FIGURE 11.TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
• FIGURE 12.TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,BY PRODUCT,2020(%)
• FIGURE 13.COMPARATIVE SHARE ANALYSIS OF MECHANICAL VALVES TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030(%)
• FIGURE 14.COMPARATIVE SHARE ANALYSIS OF BIOPROSTHETIC TISSUE (BIOLOGICAL) VALVES TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030(%)
• FIGURE 15.TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,BY INDICATIONS,2020(%)
• FIGURE 16.COMPARATIVE SHARE ANALYSIS OF MITRAL VALVE STENOSIS TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030(%)
• FIGURE 17.COMPARATIVE SHARE ANALYSIS OF MITRAL VALVE PROLAPSE TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030(%)
• FIGURE 18.COMPARATIVE SHARE ANALYSIS OF MITRAL VALVE REGURGITATION TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030(%)
• FIGURE 19.TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET BY REGION,2020
• FIGURE 20.U.S. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)
• FIGURE 21.CANADA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)
• FIGURE 22.MEXICO TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)
• FIGURE 23.GERMANY TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)
• FIGURE 24.FRANCE TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)
• FIGURE 25.U.K. TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)
• FIGURE 26.ITALY TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)
• FIGURE 27.SPAIN TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)
• FIGURE 28.REST OF EUROPE TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)
• FIGURE 29.JAPAN TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)
• FIGURE 30.CHINA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)
• FIGURE 31.INDIA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)
• FIGURE 32.AUSTRALIA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)
• FIGURE 33.SOUTH KOREA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)
• FIGURE 34.REST OF ASIA-PACIFIC TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)
• FIGURE 35.BRAZIL TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)
• FIGURE 36.SAUDI ARABIA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)
• FIGURE 37.SOUTH AFRICA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)
• FIGURE 38.REST OF LAMEA TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET,2020-2030($MILLION)
• FIGURE 39. TOP WINNING STRATEGIES, BY YEAR
• FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT
• FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY
• FIGURE 42.PRODUCT MAPPING OF TOP 10 PLAYERS
• FIGURE 43.COMPETITIVE DASHBOARD
• FIGURE 44.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
• FIGURE 45.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
• FIGURE 46.BIOTRONIK SE & CO. KG.: NET SALES ,($MILLION)
• FIGURE 47.COLIBRI HEART VALVE, LLC..: NET SALES ,($MILLION)
• FIGURE 48.EDWARDS LIFE SCIENCE CORPORATION.: NET SALES ,($MILLION)
• FIGURE 49.HLT, INC..: NET SALES ,($MILLION)
• FIGURE 50.LIVANOVA PLC.: NET SALES ,($MILLION)
• FIGURE 51.MEDTRONIC PLC.: NET SALES ,($MILLION)
• FIGURE 52.NEOVASC INC..: NET SALES ,($MILLION)
• FIGURE 53.NEOCHORD INC..: NET SALES ,($MILLION)
• FIGURE 54.CORAMAZE TECHNOLOGIES GMBH..: NET SALES ,($MILLION)

Transcatheter mitral valve repair and replacement is a minimally invasive technique for the treatment of heart-associated diseases such as mitral valve stenosis, mitral valve prolapses, and mitral valve regurgitation. In case of mitral valve misfunctioning, an individual can experience symptom such as fatigue and shortness of breath. Mitral valve diseases occurs when mitral valve does not pump enough blood out of the left ventricular chamber to supply the body with oxygen-filled blood. Mitral valve disorders are severe, if untreated, they may lead to heart failure and irregular heartbeats called arrhythmias.

The major factors that drive the growth of the global transcatheter mitral valve repair and replacement market include increase in incidence of heart diseases especially among the geriatric population, technological advancements, and introduction of novel mitral valves. However, implementation of stringent regulations by governing bodies for the approval of novel mitral valve stents, high cost of mitral valve surgeries, and risks associated with this procedure restrain the market growth. Conversely, continuous product innovations and introduction of novel mitral valves in untapped economies are anticipated to create lucrative opportunities for key market players.

The global transcatheter mitral valve repair and replacement market is segmented into product, indication, and region. According to product, the market is divided into mechanical valves and bioprosthetic tissue (biological) valves. By indication, it is categorized into mitral valve stenosis, mitral valve prolapses, and mitral valve regurgitation. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include: LivaNova Plc., Abbott Laboratories, Biotronik Pvt., Ltd., Edward Lifesciences, Medtronic Plc., Neovasc Inc., NeoChord, St. Jude Medical, Direct Flow Medical Inc., and Colibri Heart Valve, LLC.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the transcatheter mitral valve repair & replacement market analysis from 2020 to 2030 to identify the prevailing transcatheter mitral valve repair & replacement market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the transcatheter mitral valve repair & replacement market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global transcatheter mitral valve repair & replacement market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Indications

• Mitral Valve Stenosis
• Mitral Valve Prolapse
• Mitral Valve Regurgitation

By BY PRODUCT

• Mechanical Valves
• Bioprosthetic Tissue (Biological) Valves

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
• Key Market Players
  • ABBOTT LABORATORIES
  • BIOTRONIK SE & CO. KG
  • COLIBRI HEART VALVE, LLC.
  • EDWARDS LIFE SCIENCE CORPORATION
  • HLT, INC.
  • LIVANOVA PLC
  • MEDTRONIC PLC
  • NEOVASC INC.
  • NEOCHORD INC.
  • CORAMAZE TECHNOLOGIES GMBH.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

• 1.1.Report description
• 1.2.Key market segments
• 1.3.Key benefits to the stakeholders
• 1.4.Research Methodology
  • 1.4.1.Secondary research
  • 1.4.2.Primary research
  • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

• 2.1.Key findings of the study
• 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

• 3.1.Market definition and scope
• 3.2.Key findings
  • 3.2.1.Top investment pockets
• 3.3.Porter's five forces analysis
• 3.4.Top player positioning
• 3.5.Market dynamics
  • 3.5.1.Drivers
  • 3.5.2.Restraints
  • 3.5.3.Opportunities
• 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT

• 4.1 Overview
  • 4.1.1 Market size and forecast
• 4.2 Mechanical Valves
  • 4.2.1 Key market trends, growth factors and opportunities
  • 4.2.2 Market size and forecast, by region
  • 4.2.3 Market analysis by country
• 4.3 Bioprosthetic Tissue (Biological) Valves
  • 4.3.1 Key market trends, growth factors and opportunities
  • 4.3.2 Market size and forecast, by region
  • 4.3.3 Market analysis by country

CHAPTER 5: TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS

• 5.1 Overview
  • 5.1.1 Market size and forecast
• 5.2 Mitral Valve Stenosis
  • 5.2.1 Key market trends, growth factors and opportunities
  • 5.2.2 Market size and forecast, by region
  • 5.2.3 Market analysis by country
• 5.3 Mitral Valve Prolapse
  • 5.3.1 Key market trends, growth factors and opportunities
  • 5.3.2 Market size and forecast, by region
  • 5.3.3 Market analysis by country
• 5.4 Mitral Valve Regurgitation
  • 5.4.1 Key market trends, growth factors and opportunities
  • 5.4.2 Market size and forecast, by region
  • 5.4.3 Market analysis by country

CHAPTER 6: TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY REGION

• 6.1 Overview
  • 6.1.1 Market size and forecast
• 6.2 North America
  • 6.2.1 Key trends and opportunities
  • 6.2.2 North America Market size and forecast, by Product
  • 6.2.3 North America Market size and forecast, by Indications
  • 6.2.4 North America Market size and forecast, by country
    • 6.2.4.1 U.S.
    • 6.2.4.1.1 Market size and forecast, by Product
    • 6.2.4.1.2 Market size and forecast, by Indications
    • 6.2.4.2 Canada
    • 6.2.4.2.1 Market size and forecast, by Product
    • 6.2.4.2.2 Market size and forecast, by Indications
    • 6.2.4.3 Mexico
    • 6.2.4.3.1 Market size and forecast, by Product
    • 6.2.4.3.2 Market size and forecast, by Indications
• 6.3 Europe
  • 6.3.1 Key trends and opportunities
  • 6.3.2 Europe Market size and forecast, by Product
  • 6.3.3 Europe Market size and forecast, by Indications
  • 6.3.4 Europe Market size and forecast, by country
    • 6.3.4.1 Germany
    • 6.3.4.1.1 Market size and forecast, by Product
    • 6.3.4.1.2 Market size and forecast, by Indications
    • 6.3.4.2 France
    • 6.3.4.2.1 Market size and forecast, by Product
    • 6.3.4.2.2 Market size and forecast, by Indications
    • 6.3.4.3 U.K.
    • 6.3.4.3.1 Market size and forecast, by Product
    • 6.3.4.3.2 Market size and forecast, by Indications
    • 6.3.4.4 Italy
    • 6.3.4.4.1 Market size and forecast, by Product
    • 6.3.4.4.2 Market size and forecast, by Indications
    • 6.3.4.5 Spain
    • 6.3.4.5.1 Market size and forecast, by Product
    • 6.3.4.5.2 Market size and forecast, by Indications
    • 6.3.4.6 Rest of Europe
    • 6.3.4.6.1 Market size and forecast, by Product
    • 6.3.4.6.2 Market size and forecast, by Indications
• 6.4 Asia-Pacific
  • 6.4.1 Key trends and opportunities
  • 6.4.2 Asia-Pacific Market size and forecast, by Product
  • 6.4.3 Asia-Pacific Market size and forecast, by Indications
  • 6.4.4 Asia-Pacific Market size and forecast, by country
    • 6.4.4.1 Japan
    • 6.4.4.1.1 Market size and forecast, by Product
    • 6.4.4.1.2 Market size and forecast, by Indications
    • 6.4.4.2 China
    • 6.4.4.2.1 Market size and forecast, by Product
    • 6.4.4.2.2 Market size and forecast, by Indications
    • 6.4.4.3 India
    • 6.4.4.3.1 Market size and forecast, by Product
    • 6.4.4.3.2 Market size and forecast, by Indications
    • 6.4.4.4 Australia
    • 6.4.4.4.1 Market size and forecast, by Product
    • 6.4.4.4.2 Market size and forecast, by Indications
    • 6.4.4.5 South Korea
    • 6.4.4.5.1 Market size and forecast, by Product
    • 6.4.4.5.2 Market size and forecast, by Indications
    • 6.4.4.6 Rest of Asia-Pacific
    • 6.4.4.6.1 Market size and forecast, by Product
    • 6.4.4.6.2 Market size and forecast, by Indications
• 6.5 LAMEA
  • 6.5.1 Key trends and opportunities
  • 6.5.2 LAMEA Market size and forecast, by Product
  • 6.5.3 LAMEA Market size and forecast, by Indications
  • 6.5.4 LAMEA Market size and forecast, by country
    • 6.5.4.1 Brazil
    • 6.5.4.1.1 Market size and forecast, by Product
    • 6.5.4.1.2 Market size and forecast, by Indications
    • 6.5.4.2 Saudi Arabia
    • 6.5.4.2.1 Market size and forecast, by Product
    • 6.5.4.2.2 Market size and forecast, by Indications
    • 6.5.4.3 South Africa
    • 6.5.4.3.1 Market size and forecast, by Product
    • 6.5.4.3.2 Market size and forecast, by Indications
    • 6.5.4.4 Rest of LAMEA
    • 6.5.4.4.1 Market size and forecast, by Product
    • 6.5.4.4.2 Market size and forecast, by Indications

CHAPTER 7: COMPANY LANDSCAPE

• 7.1. Introduction
• 7.2. Top winning strategies
• 7.3. Product Mapping of Top 10 Player
• 7.4. Competitive Dashboard
• 7.5. Competitive Heatmap
• 7.6. Key developments

CHAPTER 8: COMPANY PROFILES

• 8.1 ABBOTT LABORATORIES
  • 8.1.1 Company overview
  • 8.1.2 Company snapshot
  • 8.1.3 Operating business segments
  • 8.1.4 Product portfolio
  • 8.1.5 Business performance
  • 8.1.6 Key strategic moves and developments
• 8.2 BIOTRONIK SE & CO. KG
  • 8.2.1 Company overview
  • 8.2.2 Company snapshot
  • 8.2.3 Operating business segments
  • 8.2.4 Product portfolio
  • 8.2.5 Business performance
  • 8.2.6 Key strategic moves and developments
• 8.3 COLIBRI HEART VALVE, LLC.
  • 8.3.1 Company overview
  • 8.3.2 Company snapshot
  • 8.3.3 Operating business segments
  • 8.3.4 Product portfolio
  • 8.3.5 Business performance
  • 8.3.6 Key strategic moves and developments
• 8.4 EDWARDS LIFE SCIENCE CORPORATION
  • 8.4.1 Company overview
  • 8.4.2 Company snapshot
  • 8.4.3 Operating business segments
  • 8.4.4 Product portfolio
  • 8.4.5 Business performance
  • 8.4.6 Key strategic moves and developments
• 8.5 HLT, INC.
  • 8.5.1 Company overview
  • 8.5.2 Company snapshot
  • 8.5.3 Operating business segments
  • 8.5.4 Product portfolio
  • 8.5.5 Business performance
  • 8.5.6 Key strategic moves and developments
• 8.6 LIVANOVA PLC
  • 8.6.1 Company overview
  • 8.6.2 Company snapshot
  • 8.6.3 Operating business segments
  • 8.6.4 Product portfolio
  • 8.6.5 Business performance
  • 8.6.6 Key strategic moves and developments
• 8.7 MEDTRONIC PLC
  • 8.7.1 Company overview
  • 8.7.2 Company snapshot
  • 8.7.3 Operating business segments
  • 8.7.4 Product portfolio
  • 8.7.5 Business performance
  • 8.7.6 Key strategic moves and developments
• 8.8 NEOVASC INC.
  • 8.8.1 Company overview
  • 8.8.2 Company snapshot
  • 8.8.3 Operating business segments
  • 8.8.4 Product portfolio
  • 8.8.5 Business performance
  • 8.8.6 Key strategic moves and developments
• 8.9 NEOCHORD INC.
  • 8.9.1 Company overview
  • 8.9.2 Company snapshot
  • 8.9.3 Operating business segments
  • 8.9.4 Product portfolio
  • 8.9.5 Business performance
  • 8.9.6 Key strategic moves and developments
• 8.10 CORAMAZE TECHNOLOGIES GMBH.
  • 8.10.1 Company overview
  • 8.10.2 Company snapshot
  • 8.10.3 Operating business segments
  • 8.10.4 Product portfolio
  • 8.10.5 Business performance
  • 8.10.6 Key strategic moves and developments